CLINICAL_TRIALS
trial_result
· 2022-06-03
Clinical Trial Update: Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema [Phase 3]
Summary
Phase 3 trial updating safety and efficacy of furosemide 40mg plus amiloride hydrochloride 10mg for edema reduction in congestive heart failure.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eurofarma Laboratorios S.A. | Conditions: Congestive Heart Failure | Phase 3 | Status: TERMINATED